These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8032286)

  • 21. Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus.
    Greene IP; Paessler S; Austgen L; Anishchenko M; Brault AC; Bowen RA; Weaver SC
    J Virol; 2005 Jul; 79(14):9128-33. PubMed ID: 15994807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venezuelan equine encephalitis.
    Weaver SC; Ferro C; Barrera R; Boshell J; Navarro JC
    Annu Rev Entomol; 2004; 49():141-74. PubMed ID: 14651460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The protective activity of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus in rodent infection via the respiratory tract].
    Filatenkov AG; Khaltaeva GG; Khlebnikova NN; Gorban' SG; Shkurnikova NN; Khamitova MF
    Vopr Virusol; 1991; 36(3):229-31. PubMed ID: 1891877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.
    Powers AM; Oberste MS; Brault AC; Rico-Hesse R; Schmura SM; Smith JF; Kang W; Sweeney WP; Weaver SC
    J Virol; 1997 Sep; 71(9):6697-705. PubMed ID: 9261393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of RNA virus attenuation approaches.
    Kenney JL; Volk SM; Pandya J; Wang E; Liang X; Weaver SC
    Vaccine; 2011 Mar; 29(12):2230-4. PubMed ID: 21288800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
    Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P
    Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ; O'Guinn ML; Parker MD
    Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.
    Kinney RM; Johnson BJ; Welch JB; Tsuchiya KR; Trent DW
    Virology; 1989 May; 170(1):19-30. PubMed ID: 2524126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
    Grieder FB; Vogel SN
    Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages.
    Grieder FB; Nguyen HT
    Microb Pathog; 1996 Aug; 21(2):85-95. PubMed ID: 8844652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus.
    Johnson BJ; Kinney RM; Kost CL; Trent DW
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1951-60. PubMed ID: 3755750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.
    Steele KE; Davis KJ; Stephan K; Kell W; Vogel P; Hart MK
    Vet Pathol; 1998 Sep; 35(5):386-97. PubMed ID: 9754544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venezuelan equine encephalitis and upper gastrointestinal bleeding in child.
    Vilcarromero S; Laguna-Torres VA; Fernández C; Gotuzzo E; Suárez L; Céspedes M; Aguilar PV; Kochel TJ
    Emerg Infect Dis; 2009 Feb; 15(2):323-5. PubMed ID: 19193285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses.
    Hunt AR; Roehrig JT
    Vaccine; 1995 Feb; 13(3):281-8. PubMed ID: 7543231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico.
    Oberste MS; Fraire M; Navarro R; Zepeda C; Zarate ML; Ludwig GV; Kondig JF; Weaver SC; Smith JF; Rico-Hesse R
    Am J Trop Med Hyg; 1998 Jul; 59(1):100-7. PubMed ID: 9684636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.